Emmessar Biotech & Nutrition Ltd.

View in App
22.13 -0.50 ▼-2.2%

26 May 2023, 04:01:00 PM
Volume: 7,711

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.ebnl.org
Market Cap 11.13 Cr.
Enterprise Value(EV) 6.02 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 1.01 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 22.12 Trailing Twelve Months Ending 2023-03
Industry PE 31.87 Trailing Twelve Months Ending 2023-03
Book Value / Share 13.34 Trailing Twelve Months Ending 2023-03
Price to Book Value 1.67 Calculated using Price: 22.27
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.50 Cr. 4,996,100 Shares
FaceValue 10
About Emmessar Biotech & Nutrition Ltd.
Emmessar Biotech & Nutrition Ltd., was originally started as Emmessar Chemical Industries Ltd on March 17,1992, for manufacturing Super Speciality Fine Chemicals. The Company succeeded in developing many Speciality Fine Chemicals in its own In-house R&D, which was recognised on January 15, 1996 by DSIR, Ministry of Science & Technology, Government of India, New Delhi .

Emmessar Biotech & Nutrition Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Emmessar Biotech & Nutrition Ltd. Performance

View details >>
1 Day
-2.21%
1 Week
-2.60%
1 Month
-11.48%
3 Month
-12.36%
6 Month
-23.43%
1 Year
-18.04%
2 Year
-20.96%
5 Year
-19.38%
10 Year
+532.29%

Emmessar Biotech & Nutrition Ltd. Fundamental Ratios

View details >>
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -17.71 -7.98 -40.75 78.73 36.00 16.42 19.40 29.10 8.01
Return on Capital Employed (%) -9.52 -10.49 -59.37 79.46 31.46 9.00 18.87 45.29 15.71
Return on Assets (%) -8.60 -5.08 -20.32 44.83 26.93 12.75 14.93 22.47 6.30

Emmessar Biotech & Nutrition Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 2 1 1 2 3 4 4 6 6 7
Non Curr. Liab. 0 0 1 1 0 0 0 0 1
Curr. Liab. 0 1 1 0 0 1 1 2 1 0
Minority Int.
Equity & Liab. 2 2 2 3 4 5 5 7 8 8
Non Curr. Assets 2 2 1 2 2 2 2 2 2 2
Curr. Assets 1 1 1 1 1 3 3 6 6 6
Misc. Exp. not W/O
Total Assets 2 2 2 3 4 5 5 7 8 8

Emmessar Biotech & Nutrition Ltd. Profit and Loss

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. TTM
Net Sales 1 2 2 3 1 1 3 7 0 1
Other Income 0 0 0 1 1 1 1 1 2 2
Total Income 1 2 2 4 3 2 5 8 2 3
Total Expenditure -1 -2 -2 -2 -2 -1 -4 -6 -1 -2
PBIDT 0 0 0 1 1 1 1 2 1 1
Interest 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 0 0 0 -1 0 0
Exceptional Items -1 0 0
PAT 0 0 0 1 1 1 1 1 0 1
Adjusted EPS -1 0 -1 2 2 1 2 3 1 1

Emmessar Biotech & Nutrition Ltd. Cash Flow

View details >>
Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 1 1 0 1 0 2
Cash Fr. Inv. 0 0 -1 -1 0 -1 0 -3
Cash Fr. Finan.
Net Change 0 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 1 0

Emmessar Biotech & Nutrition Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 58.50 58.51 58.50 58.50 58.51 58.19 56.31 58.53 59.08
Public 41.50 41.49 41.50 41.50 41.49 41.81 43.69 41.47 40.92
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Emmessar Biotech & Nutrition Ltd. Announcements

View details >>
Tue, 23 May 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
In furtherance to our letter dated May 20 2023 intimating the outcome of the Board Meeting please find enclosed the newspaper cutting where the Audited Financial Results of the Company for the fourth quarter / year ended March 31 2023 was published in Free Press Journal and Nav Shakti on May 23 2023.The aforesaid information will also be hosted on the Companys website i.e. www.ebnl.org. You are kindly requested to take this on record.
Sat, 20 May 2023
Board Meeting Outcome for Outcome Of The Board Meeting Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.
With reference to the above subject please be informed that the Board of Directors at its meeting held today has transacted the following business.1. The Board has considered and approved the Audited Standalone Financial Results of the company for the fourth quarter / financial year ended March 31 2023. The Results will be made available on the website of the Company: http://www.ebnl.org in due compliance with the Listing Regulations.2. The Board took on record the Auditors Report issued by the Statutory Auditors for the Audited Standalone Financial Result of the Company for the Financial Year 2022 - 2023 3. Declaration pursuant to Regulation 33 (3) (d) of SEBI [LODR] Regulations 2015.The Board meeting commenced at 02.45 pm and concluded at 04.30 pm.You are kindly requested to take same on record.
Mon, 24 Apr 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to the provisions of Regulation 47(3) of the SEBI (Listing Obligations and DisclosureRequirements) Regulations 2015 the newspaper clippings regarding the intimation of Board Meeting to be held on 20 th May 2023 at 2.30 pm published in The Free Press Journal in English and Navshaktiin Marathi dated Saturday 22 nd April 2023 are attached.You are kindly requested to take this on record.

Emmessar Biotech & Nutrition Ltd. Technical Scans

View details >>
Fri, 26 May 2023
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Emmessar Biotech & Nutrition Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 232,891.45 969.90 +2.6%
Divi's Laboratories Ltd. 93,212.66 3,514.00 +2.3%
Cipla Ltd. 76,767.04 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. 75,437.96 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. 66,286.16 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. 57,611.88 1,700.25 -0.1%
Mankind Pharma Ltd. 53,007.87 1,323.60 -0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 27.48 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2023-03 51.00 3,514.00 +2.3%
Cipla Ltd. Consolidated 2023-03 27.40 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 16.74 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 86.68 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 69.29 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 39.70 1,323.60 -0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.16 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2023-03 7.28 3,514.00 +2.3%
Cipla Ltd. Consolidated 2023-03 3.28 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.24 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 10.75 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 9.03 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 5.10 1,323.60 -0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 0.04 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 0.14 1,323.60 -0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 13.10 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,323.60 -0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 13.10 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,323.60 -0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 21,763.34 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 7,781.56 1,323.60 -0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 2,559.47 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 1,452.96 1,323.60 -0.3%

Emmessar Biotech & Nutrition Ltd. FAQ's

What is Emmessar Biotech&Nut share price?
Can I buy Emmessar Biotech&Nut shares now?
What is the Market Cap of Emmessar Biotech&Nut?
What are the key metrics to analyse Emmessar Biotech&Nut?
What is the 52 Week High and Low of Emmessar Biotech&Nut?
What is the trend of Emmessar Biotech&Nut share price?